Dyspepsia
📧 Sign up to get email alerts when something new happens for Dyspepsia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Results: Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility [NA]
A completed feasibility study evaluating magnetically controlled capsule endoscopy for gastric motility disorders (gastroparesis and dyspeps…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication [Phase 4]
Phase 4 clinical trial comparing vonoprazan-based triple therapy to esomeprazole-based triple therapy for Helicobacter pylori eradication. T…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Symptoms and Quality of Life in Patients With Heterotopic Gastric Mucosa (HGM)
The study is currently recruiting to assess symptoms and quality of life in patients with heterotopic gastric mucosa of the proximal esophag…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Domperidone in Treating Patients With Gastrointestinal Disorders [Phase 3]
A Phase 3 clinical trial evaluating domperidone for several gastrointestinal disorders is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Holy Basil in The Treatment of Dyspepsia [Phase 2, Phase 3]
Mahidol University is recruiting for a Phase 2/Phase 3 clinical trial evaluating Holy Basil (Ocimum tenuiflorum) for dyspepsia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Predicting Peptic Complications Using H. Pylori Serology and Gastric Ultrasound
A clinical trial evaluating whether Helicobacter pylori serology and gastric ultrasound can predict peptic complications.
-
FDA approval · 2026-02-12FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength, a famotidine-containing product from Kenvue Brands LLC.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: BSGM to Evaluate Patients With GI Symptoms
This ClinicalTrials.gov entry describes a pediatric study evaluating gastrointestinal motility disorders and related functional GI symptoms.…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori Infection [NA]
An ongoing clinical trial comparing triple therapy versus quadruple therapy for Helicobacter pylori infection, with enrollment by invitation…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Functional Digestive Disorders Observatory
Clinical trial update announcing recruitment for the Functional Digestive Disorders Observatory. The program investigates multiple functiona…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms
This clinical trial investigates whether eradicating Helicobacter pylori improves gastrointestinal symptoms in individuals with H. pylori in…
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Optimizing Proton Pump Inhibitors (PPI) Prescribing With EHR-Based Decision Support [NA]
A UCLA-sponsored clinical trial seeks to optimize proton pump inhibitor prescribing using electronic health record decision support and to s…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
A clinical trial is evaluating the carbon footprint of diagnostic upper GI endoscopy in dyspeptic patients compared with therapeutic upper G…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 4]
A Phase 4 trial is evaluating Saccharomyces boulardii in combination with bismuth quadruple therapy as a rescue treatment for Helicobacter p…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Treatment of Functional Abdominal Distension by Non-instrumental Biofeedback [NA]
A completed clinical trial from Hospital Universitari Vall d'Hebron Research Institute evaluated non-instrumental biofeedback to treat funct…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Visible Abdominal Distension [NA]
The entry indicates a recruiting clinical trial at Hospital Universitari Vall d'Hebron Research Institute investigating treatments for irrit…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis [NA]
A clinical trial update indicates that a study evaluating vagal nerve stimulation for functional dyspepsia and gastroparesis is currently re…
-
FDA approval · 2025-09-30FDA Approved: PEPCID COMPLETE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for Pepcid Complete (famotidine with calcium carbonate and magnesium hydroxide) chewable tablets to …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia [NA]
A recruiting study from Massachusetts General Hospital testing exposure-based cognitive-behavioral therapy for individuals with Avoidant/Res…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: A Study of Chios Mastic Water in Dyspepsia [NA]
The clinical trial evaluating Chios Mastic Water for dyspepsia is currently in recruitment.
-
CLINICAL_TRIALS other · 2025-08-19Clinical Trial Update: High Resolution Gastric Mapping and Gastroduodenal Manometry [NA]
A Mayo Clinic-sponsored clinical trial investigating high-resolution gastric mapping and gastroduodenal manometry for dyspepsia is currently…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial [Phase 4]
Phase 4 clinical trial evaluating vonoprazan combined with different antibiotics in dual therapy for Helicobacter pylori eradication, curren…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Exocrine Pancreatic Insufficiency and Functional Dyspepsia
This clinical trial update indicates that the study on Exocrine pancreatic insufficiency and dyspepsia is not yet recruiting.
-
FDA approval · 2025-07-16FDA Approved: FAMOTIDINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for famotidine from Sagent Pharmaceuticals, marking the approval of a generic product.